409 related articles for article (PubMed ID: 17996279)
1. Heparin: from animal organ extract to designer drug.
Middeldorp S
Thromb Res; 2008; 122(6):753-62. PubMed ID: 17996279
[TBL] [Abstract][Full Text] [Related]
2. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
3. From heparins to factor Xa inhibitors and beyond.
Alban S
Eur J Clin Invest; 2005 Mar; 35 Suppl 1():12-20. PubMed ID: 15701143
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin in the treatment of pulmonary embolism.
Ageno W; Turpie AG
Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
[TBL] [Abstract][Full Text] [Related]
5. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis.
Bauer KA
Am J Orthop (Belle Mead NJ); 2002 Nov; 31(11 Suppl):4-10. PubMed ID: 12463577
[TBL] [Abstract][Full Text] [Related]
6. Emerging anticoagulants for the treatment of venous thromboembolism.
Weitz JI
Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
[TBL] [Abstract][Full Text] [Related]
7. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
[TBL] [Abstract][Full Text] [Related]
8. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
9. Heparin and low-molecular-weight heparin.
Gray E; Mulloy B; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
[TBL] [Abstract][Full Text] [Related]
10. [New medical anticoagulants].
Choussat R; Montalescot G
Rev Mal Respir; 1999 Nov; 16(5 Pt 2):985-95. PubMed ID: 10907447
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
Daskalopoulos ME; Daskalopoulou SS; Liapis CD
Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
[TBL] [Abstract][Full Text] [Related]
12. New anticoagulants.
Bauer KA
Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376
[TBL] [Abstract][Full Text] [Related]
13. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
14. Update in the treatment of venous thromboembolism.
Garcia DA; Spyropoulos AC
Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085
[TBL] [Abstract][Full Text] [Related]
15. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Haas S
Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
[TBL] [Abstract][Full Text] [Related]
16. [From heparin to synthetic antithrombotic drugs].
Palareti G; Cosmi B
Minerva Anestesiol; 2001 Sep; 67(9 Suppl 1):76-81. PubMed ID: 11778099
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
Fiessinger JN
Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
[TBL] [Abstract][Full Text] [Related]
18. Emerging anticoagulants: mechanism of action and future potential.
Klement P; Rak J
Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
[TBL] [Abstract][Full Text] [Related]
19. From unfractionated heparins to low molecular weight heparins.
Hirsh J
Acta Chir Scand Suppl; 1990; 556():42-50. PubMed ID: 1705072
[TBL] [Abstract][Full Text] [Related]
20. New anticoagulants for treatment of venous thromboembolism.
Weitz JI
Circulation; 2004 Aug; 110(9 Suppl 1):I19-26. PubMed ID: 15339877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
